Skip to main content
. 2018 May 23;9(6):1054–1058. doi: 10.1039/c8md00057c

Table 3. The docking results of the target compounds.

Entry ΔG a K i b Entry ΔG a K i b
8a –9.53 0.104 8l –10.52 0.019
8b –8.53 0.561 8m –9.65 0.084
8c –9.00 0.253 8n –9.20 0.179
8d –8.95 0.274 8o –9.56 0.098
8e –9.66 0.082 8p –9.10 0.214
8f –9.14 0.198 8q –8.59 0.503
8g –9.32 0.147 8r –9.76 0.069
8h –9.37 0.135 8s –8.59 0.505
8i –9.61 0.090 8t –8.31 0.815
8j –10.28 0.029 8u –10.27 0.030
8k –9.42 0.125 8v –9.45 0.119
Sorafenib –11.03 0.008
Axitinib –9.15 0.195

aBinding free energy (kcal mol–1).

bInhibition constant (μM).